Literature DB >> 10686005

Molecular basis of Cromer blood group antigens.

D M Lublin1, S Kompelli, J R Storry, M E Reid.   

Abstract

BACKGROUND: The Cromer blood group system consists of 10 antigens located on decay-accelerating factor (DAF). Previous molecular genetic analysis has determined the basis for four of these antigens. The present study was undertaken to identify the mutations that determine the remaining antigens. STUDY DESIGN AND
METHOD: Existing or new data were used to localize each Cromer system antigen to a specific short consensus repeat (SCR) domain of DAF. The exon encoding that SCR domain was amplified by using the polymerase chain reaction (PCR) on genomic DNA obtained from individuals of that Cromer phenotype, and the DNA product was subjected to DNA sequence analysis.
RESULTS: The Tc(a)/Tc(c) polymorphism is due to an R18P amino acid substitution in SCR1 of DAF. The Es(a+)/Es(a-) polymorphism is due to an I46N mutation in SCR1 of DAF. The WES(b)/WES(a) polymorphism is due to an L48R mutation in SCR1 of DAF. The UMC+/UMC- polymorphism is due to a T216M substitution in SCR4 of DAF.
CONCLUSIONS: With information from previous reports and the findings of this study, the molecular genetic basis of all known alleles of the Cromer blood group system has been elucidated. Single amino acid substitutions are responsible for 9 of the 10 antigens (all except the multiple-epitope antigen IFC).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10686005     DOI: 10.1046/j.1537-2995.2000.40020208.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  5 in total

Review 1.  Pathogenesis of Afa/Dr diffusely adhering Escherichia coli.

Authors:  Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

2.  Genomic coordinates and continental distribution of 120 blood group variants reported by the 1000 Genomes Project.

Authors:  Celina Montemayor-Garcia; Panagiota Karagianni; David A Stiles; Erika M Reese; Danielle A Smellie; Debrean A Loy; Kimberly Y Levy; Magdalene Nwokocha; Marina U Bueno; Jeffery L Miller; Harvey G Klein
Journal:  Transfusion       Date:  2018-10-12       Impact factor: 3.157

3.  Discovery, linkage disequilibrium and association analyses of polymorphisms of the immune complement inhibitor, decay-accelerating factor gene (DAF/CD55) in type 1 diabetes.

Authors:  Hidenori Taniguchi; Christopher E Lowe; Jason D Cooper; Deborah J Smyth; Rebecca Bailey; Sarah Nutland; Barry C Healy; Alex C Lam; Oliver Burren; Neil M Walker; Luc J Smink; Linda S Wicker; John A Todd
Journal:  BMC Genet       Date:  2006-04-20       Impact factor: 2.797

4.  BOOGIE: Predicting Blood Groups from High Throughput Sequencing Data.

Authors:  Manuel Giollo; Giovanni Minervini; Marta Scalzotto; Emanuela Leonardi; Carlo Ferrari; Silvio C E Tosatto
Journal:  PLoS One       Date:  2015-04-20       Impact factor: 3.240

Review 5.  Initiation and regulation of complement during hemolytic transfusion reactions.

Authors:  Sean R Stowell; Anne M Winkler; Cheryl L Maier; C Maridith Arthur; Nicole H Smith; Kathryn R Girard-Pierce; Richard D Cummings; James C Zimring; Jeanne E Hendrickson
Journal:  Clin Dev Immunol       Date:  2012-10-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.